US Stock Market Move | "Reported that Merck & Co., Inc. is in talks to acquire Revolution Medicines (RVMD.US), leading to a pre-market increase of nearly 15%."

On Friday, Revolution Medicines (RVMD.US) continued to rise by nearly 15% in pre-market trading, with the opening indicating a new all-time high, following a cumulative increase of 35% over the previous two trading days. According to reports, Merck & Co., Inc. (MRK.US) is in talks to acquire the biotechnology company Revolution Medicines, which focuses on the cancer field. The report cited sources familiar with the matter stating that the discussed deal price is between $28 billion and $32 billion. If the deal is reached, it would be one of the largest pharmaceutical industry transactions since Pfizer Inc. acquired Seagen for $43 billion at the end of 2023. It is worth mentioning that on Wednesday, there were reports that AbbVie, Inc. (ABBV.US) was in "detailed" negotiations to acquire Revolution Medicines, with the valuation of the latter, a company that has not yet launched any products, potentially exceeding $20 billion. However, AbbVie later responded that the company had not been in negotiations to acquire Revolution Medicines.